Head-to-head comparisons of medication uses, side effects, warnings, and more.
Vyepti (eptinezumab)
Emgality (galcanezumab)
Vyepti (eptinezumab)
Emgality (galcanezumab)
Summary of Vyepti vs. Emgality
Summary for CGRP receptor blocker
Prescription only
Vyepti (eptinezumab or eptinezumab-jjmr) is a medication that's used to prevent migraines in adults. The dose is given as an infusion through the veins at a provider's office or clinic every 3 months. Side effects aren't common, but they can include common cold symptoms, itching, and flushing. Vyepti (eptinezumab) is only available as a brand name.
Summary for CGRP antagonist
Prescription only
Emgality (galcanezumab or galcanezumab-gnlm) is an injectable medication that can help prevent migraine attacks in adults. It can also help treat cluster headaches in adults. This medication is a monoclonal antibody that works as a CGRP antagonist. It blocks the CGRP protein in the brain that can cause migraine and headache pain. Emgality (galcanezumab) comes as a prefilled pen and syringe. You inject one dose of the medication under the skin monthly. Some common side effects include pain, itching, and redness at the injection site.